(+)-dexrazoxane decreases expression ISO RGD:1557957 6480464 Dexrazoxane results in decreased expression of ATP5F1B mRNA CTD PMID:26873546 (Z)-3-butylidenephthalide decreases expression ISO RGD:1344847 6480464 butylidenephthalide results in decreased expression of ATP5F1B protein CTD PMID:23770345 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of ATP5F1B mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO RGD:1557957 6480464 o, p'-DDT results in increased expression of ATP5F1B mRNA CTD PMID:24096037 1,2-dimethylhydrazine increases expression ISO RGD:1557957 6480464 1, 2-Dimethylhydrazine results in increased expression of ATP5F1B mRNA CTD PMID:22206623 1,3-dinitrobenzene increases metabolic processing EXP 6480464 3-dinitrobenzene results in increased metabolism of ATP5F1B protein CTD PMID:21402099 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:1557957 6480464 Levodopa inhibits the reaction [1-Methyl-4-phenyl-1 more ... CTD PMID:23562983 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine increases expression ISO RGD:1557957 6480464 1-Methyl-4-phenyl-1 more ... CTD PMID:23562983 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ATP5F1B mRNA CTD PMID:19400957 , PMID:24096037 17alpha-ethynylestradiol affects expression ISO RGD:1557957 6480464 Ethinyl Estradiol affects the expression of ATP5F1B mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:1557957 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1B mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:1557957 6480464 Ethinyl Estradiol results in increased expression of ATP5F1B mRNA CTD PMID:17942748 more ... 17beta-estradiol increases expression ISO RGD:1344847 6480464 Estradiol results in increased expression of ATP5F1B mRNA CTD PMID:20211987 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5F1B protein] CTD PMID:21136691 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1557957 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1B protein CTD PMID:29935226 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1B mRNA CTD PMID:33387578 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1557957 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5F1B mRNA CTD PMID:20399798 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1557957 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1B mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1557957 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5F1B mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:1557957 6480464 2 more ... CTD PMID:16451863 , PMID:18550172 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ATP5F1B mRNA CTD PMID:21346803 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid affects expression EXP 6480464 Nafenopin affects the expression of ATP5F1B protein CTD PMID:10903494 4,4'-sulfonyldiphenol increases expression ISO RGD:1344847 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP5F1B protein CTD PMID:34186270 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1344847 6480464 [trichostatin A co-treated with Decitabine] results in increased expression of ATP5F1B protein CTD PMID:19294695 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22248470 acrolein affects metabolic processing ISO RGD:1557957 6480464 Acrolein affects the metabolism of ATP5F1B protein CTD PMID:17921335 aflatoxin B1 increases expression ISO RGD:1557957 6480464 Aflatoxin B1 results in increased expression of ATP5F1B mRNA CTD PMID:19770486 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of ATP5F1B mRNA CTD PMID:17991464 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP5F1B mRNA CTD PMID:16483693 aniline increases nitrosation EXP 6480464 aniline results in increased nitrosation of ATP5F1B protein CTD PMID:21708182 aristolochic acid A increases expression ISO RGD:1344847 6480464 aristolochic acid I results in increased expression of ATP5F1B protein CTD PMID:33212167 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of ATP5F1B protein CTD PMID:21791222 arsane increases expression ISO RGD:1344847 6480464 Arsenic results in increased expression of ATP5F1B protein CTD PMID:21514422 arsane increases expression EXP 6480464 Arsenic results in increased expression of ATP5F1B protein CTD PMID:34352348 arsenic atom increases expression ISO RGD:1344847 6480464 Arsenic results in increased expression of ATP5F1B protein CTD PMID:21514422 arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of ATP5F1B protein CTD PMID:34352348 atrazine decreases expression ISO RGD:1344847 6480464 Atrazine results in decreased expression of ATP5F1B mRNA CTD PMID:22378314 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein, [Piperonyl Butoxide co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein CTD PMID:28903497 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1557957 6480464 Diethylhexyl Phthalate results in increased expression of ATP5F1B mRNA CTD PMID:19245819 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP5F1B mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1344847 6480464 bisphenol A results in decreased expression of ATP5F1B protein CTD PMID:34186270 bisphenol A increases expression ISO RGD:1344847 6480464 bisphenol A results in increased expression of ATP5F1B protein CTD PMID:33376534 bisphenol A increases methylation ISO RGD:1557957 6480464 bisphenol A results in increased methylation of ATP5F1B promoter CTD PMID:27312807 bisphenol A affects expression ISO RGD:1344847 6480464 bisphenol A affects the expression of ATP5F1B mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1557957 6480464 bisphenol A results in increased expression of ATP5F1B mRNA CTD PMID:33221593 bisphenol A decreases expression ISO RGD:1557957 6480464 bisphenol A results in decreased expression of ATP5F1B protein CTD PMID:28279065 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP5F1B mRNA CTD PMID:30816183 , PMID:34947998 Bisphenol B increases expression ISO RGD:1344847 6480464 bisphenol B results in increased expression of ATP5F1B protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:1344847 6480464 bisphenol F results in increased expression of ATP5F1B protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of ATP5F1B protein CTD PMID:25933445 cadmium atom multiple interactions ISO RGD:1344847 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP5F1B protein CTD PMID:33040242 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP5F1B protein CTD PMID:21699967 cadmium dichloride multiple interactions ISO RGD:1344847 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP5F1B protein CTD PMID:33040242 captan increases expression ISO RGD:1557957 6480464 Captan results in increased expression of ATP5F1B mRNA CTD PMID:31558096 carbon nanotube affects expression ISO RGD:1557957 6480464 Nanotubes, Carbon affects the expression of ATP5F1B protein CTD PMID:21135415 carbon nanotube increases expression ISO RGD:1557957 6480464 Nanotubes, Carbon results in increased expression of ATP5F1B mRNA CTD PMID:25620056 carbon nanotube multiple interactions ISO RGD:1557957 6480464 [Nanotubes more ... CTD PMID:28807745 carbon nanotube decreases expression ISO RGD:1557957 6480464 Nanotubes, Carbon analog results in decreased expression of ATP5F1B mRNA CTD PMID:25620056 chloropicrin affects expression ISO RGD:1344847 6480464 chloropicrin affects the expression of ATP5F1B mRNA CTD PMID:26352163 choline multiple interactions ISO RGD:1557957 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATP5F1B gene CTD PMID:20938992 chromium trinitrate increases expression ISO RGD:1557957 6480464 chromium nitrate results in increased expression of ATP5F1B protein CTD PMID:19771553 clobetasol increases expression ISO RGD:1557957 6480464 Clobetasol results in increased expression of ATP5F1B mRNA CTD PMID:27462272 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ATP5F1B protein CTD PMID:16470657 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of ATP5F1B protein CTD PMID:19441803 cocaine decreases expression ISO RGD:1344847 6480464 Cocaine results in decreased expression of ATP5F1B protein CTD PMID:17075605 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1B mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1B mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:1344847 6480464 Copper Sulfate results in decreased expression of ATP5F1B mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1344847 6480464 Cyclosporine results in decreased expression of ATP5F1B mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone decreases expression ISO RGD:1557957 6480464 Dexamethasone results in decreased expression of ATP5F1B protein CTD PMID:33567340 diclofenac multiple interactions EXP 6480464 [Diclofenac co-treated with lipopolysaccharide, E coli O55-B5] results in increased expression of ATP5F1B protein CTD PMID:25772430 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of ATP5F1B protein CTD PMID:25772430 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of ATP5F1B protein CTD PMID:21161181 dioxygen decreases expression ISO RGD:1557957 6480464 Oxygen deficiency results in decreased expression of ATP5F1B protein CTD PMID:25937538 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ATP5F1B mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1344847 6480464 Doxorubicin results in decreased expression of ATP5F1B mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1557957 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ATP5F1B protein] CTD PMID:21251210 doxorubicin increases expression ISO RGD:1557957 6480464 Doxorubicin results in increased expression of ATP5F1B protein CTD PMID:21251210 doxorubicin decreases expression ISO RGD:1557957 6480464 Doxorubicin results in decreased expression of ATP5F1B mRNA, Doxorubicin results in decreased expression of ATP5F1B protein CTD PMID:26873546 , PMID:34246718 enzyme inhibitor multiple interactions ISO RGD:1344847 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATP5F1B protein CTD PMID:23301498 ethanol increases expression ISO RGD:1344847 6480464 Ethanol results in increased expression of ATP5F1B protein CTD PMID:20621659 ethanol multiple interactions ISO RGD:1557957 6480464 Ethanol affects the expression of and affects the splicing of ATP5F1B mRNA CTD PMID:30319688 fenpyroximate decreases expression ISO RGD:1344847 6480464 fenpyroximate results in decreased expression of ATP5F1B mRNA CTD PMID:33512557 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ATP5F1B mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1557957 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATP5F1B gene CTD PMID:20938992 folic acid decreases expression ISO RGD:1557957 6480464 Folic Acid results in decreased expression of ATP5F1B CTD PMID:24275386 folpet increases expression ISO RGD:1557957 6480464 folpet results in increased expression of ATP5F1B mRNA CTD PMID:31558096 fulvestrant increases expression ISO RGD:1344847 6480464 fulvestrant results in increased expression of ATP5F1B mRNA CTD PMID:20211987 furan affects binding EXP 6480464 furan binds to ATP5F1B protein CTD PMID:22240984 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of ATP5F1B mRNA CTD PMID:26302742 glyphosate increases expression ISO RGD:1557957 6480464 glyphosate results in increased expression of ATP5F1B mRNA CTD PMID:36608876 gold atom multiple interactions ISO RGD:1557957 6480464 Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein CTD PMID:24780912 gold(0) multiple interactions ISO RGD:1557957 6480464 Gold analog results in increased expression of and results in decreased phosphorylation of ATP5F1B protein CTD PMID:24780912 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of ATP5F1B protein CTD PMID:23178681 hydrogen peroxide affects expression ISO RGD:1344847 6480464 Hydrogen Peroxide affects the expression of ATP5F1B mRNA CTD PMID:20044591 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ATP5F1B protein CTD PMID:23178681 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 isoniazide affects expression ISO RGD:1557957 6480464 Isoniazid affects the expression of ATP5F1B mRNA CTD PMID:24848797 ivermectin decreases expression ISO RGD:1344847 6480464 Ivermectin results in decreased expression of ATP5F1B protein CTD PMID:32959892 josamycin affects response to substance ISO RGD:1344847 6480464 ATP5F1B protein affects the susceptibility to Josamycin CTD PMID:31915244 L-ascorbic acid increases expression ISO RGD:1557957 6480464 Ascorbic Acid results in increased expression of ATP5F1B protein CTD PMID:22139585 L-methionine multiple interactions ISO RGD:1557957 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ATP5F1B gene CTD PMID:20938992 lead(0) decreases expression ISO RGD:1344847 6480464 Lead results in decreased expression of ATP5F1B mRNA CTD PMID:19921347 lipopolysaccharide decreases expression ISO RGD:1344847 6480464 Lipopolysaccharides results in decreased expression of ATP5F1B mRNA CTD PMID:31059760 lipopolysaccharide multiple interactions ISO RGD:1344847 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1B mRNA CTD PMID:31059760 lithium atom increases expression EXP 6480464 Lithium results in increased expression of ATP5F1B protein CTD PMID:18296634 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of ATP5F1B protein CTD PMID:18296634 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of ATP5F1B protein CTD PMID:19826936 methapyrilene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Methapyrilene] results in decreased expression of ATP5F1B protein CTD PMID:28903497 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of ATP5F1B protein CTD PMID:30467583 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of ATP5F1B mRNA CTD PMID:28903497 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of ATP5F1B gene CTD PMID:23303685 methoxychlor decreases expression EXP 6480464 Methoxychlor results in decreased expression of ATP5F1B mRNA CTD PMID:23303685 mitoxantrone decreases expression ISO RGD:1557957 6480464 Mitoxantrone results in decreased expression of ATP5F1B protein CTD PMID:34246718 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1B mRNA CTD PMID:28659758 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:1344847 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA] CTD PMID:20860658 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein more ... CTD PMID:28903497 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of ATP5F1B protein CTD PMID:19716841 nafenopin affects expression EXP 6480464 Nafenopin affects the expression of ATP5F1B protein CTD PMID:10903494 naphthalene decreases expression ISO RGD:1557957 6480464 naphthalene results in decreased expression of ATP5F1B protein CTD PMID:19438287 naphthalene affects binding ISO RGD:1557957 6480464 naphthalene metabolite binds to ATP5F1B protein CTD PMID:15892573 nicotinic acid decreases expression ISO RGD:1344847 6480464 Niacin results in decreased expression of ATP5F1B protein CTD PMID:18316796 nitric oxide increases expression ISO RGD:1557957 6480464 Nitric Oxide deficiency results in increased expression of ATP5F1B mRNA CTD PMID:15878706 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of ATP5F1B protein CTD PMID:19260726 ochratoxin A increases expression ISO RGD:1344847 6480464 ochratoxin A results in increased expression of ATP5F1B mRNA CTD PMID:17316727 ochratoxin A increases expression ISO RGD:1557957 6480464 ochratoxin A results in increased expression of ATP5F1B protein CTD PMID:19445961 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of ATP5F1B mRNA CTD PMID:30316929 paracetamol decreases expression ISO RGD:1344847 6480464 Acetaminophen results in decreased expression of ATP5F1B mRNA CTD PMID:25704631 , PMID:29067470 paracetamol increases expression ISO RGD:1557957 6480464 Acetaminophen results in increased expression of ATP5F1B protein CTD PMID:21329376 paracetamol multiple interactions ISO RGD:1344847 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5F1B mRNA CTD PMID:31059760 paraoxon increases expression ISO RGD:1344847 6480464 Paraoxon results in increased expression of ATP5F1B protein CTD PMID:20931991 perfluorooctanoic acid increases expression ISO RGD:1344847 6480464 perfluorooctanoic acid results in increased expression of ATP5F1B protein CTD PMID:22609092 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1B mRNA CTD PMID:28659758 phenethyl isothiocyanate affects binding ISO RGD:1344847 6480464 ATP5F1B protein binds to phenethyl isothiocyanate CTD PMID:21838287 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ATP5F1B mRNA CTD PMID:15215175 pioglitazone decreases expression ISO RGD:1344847 6480464 pioglitazone results in decreased expression of ATP5F1B mRNA CTD PMID:20860658 piperonyl butoxide multiple interactions EXP 6480464 [Piperonyl Butoxide co-treated with beta-Naphthoflavone] results in decreased expression of ATP5F1B protein CTD PMID:28903497 potassium chromate increases expression ISO RGD:1557957 6480464 potassium chromate(VI) results in increased expression of ATP5F1B protein CTD PMID:19771553 potassium dichromate increases expression ISO RGD:1557957 6480464 Potassium Dichromate results in increased expression of ATP5F1B protein CTD PMID:19771553 procymidone decreases expression ISO RGD:1557957 6480464 procymidone results in decreased expression of ATP5B mRNA CTD PMID:35913088 progesterone increases phosphorylation EXP 6480464 Progesterone results in increased phosphorylation of ATP5F1B protein CTD PMID:17303654 promethazine decreases expression EXP 6480464 Promethazine results in decreased expression of ATP5F1B mRNA CTD PMID:28903497 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1B mRNA CTD PMID:28659758 quercetin affects binding ISO RGD:1344847 6480464 Quercetin analog binds to ATP5F1B protein CTD PMID:21798748 rotenone decreases expression ISO RGD:1344847 6480464 Rotenone results in decreased expression of ATP5F1B mRNA CTD PMID:33512557 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATP5F1B protein CTD PMID:35544339 rotenone increases oxidation EXP 6480464 Rotenone results in increased oxidation of ATP5F1B protein CTD PMID:30951809 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression ISO RGD:1557957 6480464 Buthionine Sulfoximine results in increased expression of ATP5F1B mRNA CTD PMID:15878706 silicon dioxide affects secretion ISO RGD:1344847 6480464 Silicon Dioxide analog affects the secretion of ATP5F1B protein CTD PMID:25895662 sodium arsenite increases expression ISO RGD:1344847 6480464 sodium arsenite results in increased expression of ATP5F1B protein CTD PMID:21925251 sodium arsenite increases expression ISO RGD:1557957 6480464 sodium arsenite results in increased expression of ATP5F1B protein CTD PMID:29044176 sodium fluoride decreases expression ISO RGD:1557957 6480464 Sodium Fluoride results in decreased expression of ATP5F1B protein CTD PMID:27548804 sodium fluoride increases expression ISO RGD:1557957 6480464 Sodium Fluoride results in increased expression of ATP5F1B protein CTD PMID:27548804 sodium nitrate multiple interactions ISO RGD:1557957 6480464 sodium nitrate inhibits the reaction [Doxorubicin results in increased expression of ATP5F1B protein] CTD PMID:21251210 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP5F1B protein CTD PMID:21136691 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5F1B protein] CTD PMID:21136691 sulforaphane affects binding ISO RGD:1344847 6480464 ATP5F1B protein binds to sulforaphane CTD PMID:21838287 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ATP5F1B protein CTD PMID:26141394 tamoxifen increases expression ISO RGD:1344847 6480464 Tamoxifen results in increased expression of ATP5F1B mRNA CTD PMID:20211987 tamoxifen increases expression ISO RGD:1557957 6480464 Tamoxifen results in increased expression of ATP5F1B mRNA CTD PMID:19400957 tamoxifen affects expression ISO RGD:1557957 6480464 Tamoxifen affects the expression of ATP5F1B mRNA CTD PMID:17555576 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of ATP5F1B mRNA CTD PMID:19400957 tanespimycin decreases expression ISO RGD:1344847 6480464 tanespimycin analog results in decreased expression of ATP5F1B protein CTD PMID:31370342 testosterone multiple interactions ISO RGD:1557957 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in decreased expression of ATP5F1B mRNA] CTD PMID:21045173 testosterone decreases expression ISO RGD:1557957 6480464 Testosterone deficiency results in decreased expression of ATP5F1B mRNA CTD PMID:21045173 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ATP5F1B mRNA CTD PMID:28903497 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of ATP5F1B protein CTD PMID:28903497 titanium dioxide decreases expression ISO RGD:1557957 6480464 titanium dioxide results in decreased expression of ATP5F1B mRNA CTD PMID:23557971 tolcapone affects binding EXP 6480464 tolcapone binds to ATP5F1B protein CTD PMID:19783845 toluene affects expression EXP 6480464 Toluene affects the expression of ATP5F1B mRNA CTD PMID:21827849 trichostatin A multiple interactions ISO RGD:1344847 6480464 [trichostatin A co-treated with decitabine] results in increased expression of ATP5F1B protein CTD PMID:19294695 trichostatin A affects expression ISO RGD:1344847 6480464 trichostatin A affects the expression of ATP5F1B protein CTD PMID:19294695 trimellitic anhydride increases expression ISO RGD:1557957 6480464 trimellitic anhydride results in increased expression of ATP5F1B mRNA CTD PMID:19042947 triptonide increases expression ISO RGD:1557957 6480464 triptonide results in increased expression of ATP5F1B mRNA CTD PMID:33045310 troglitazone multiple interactions ISO RGD:1344847 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA], PPARGC1A protein inhibits the reaction [troglitazone results in decreased expression of ATP5F1B mRNA] CTD PMID:20860658 troglitazone decreases expression ISO RGD:1557957 6480464 Troglitazone results in decreased expression of ATP5F1B protein CTD PMID:18495193 troglitazone decreases expression ISO RGD:1344847 6480464 troglitazone results in decreased expression of ATP5F1B mRNA CTD PMID:20860658 valproic acid decreases expression ISO RGD:1344847 6480464 Valproic Acid results in decreased expression of ATP5F1B mRNA CTD PMID:29501571 valproic acid affects expression ISO RGD:1557957 6480464 Valproic Acid affects the expression of ATP5F1B mRNA CTD PMID:17292431 , PMID:17963808 valproic acid increases methylation ISO RGD:1344847 6480464 Valproic Acid results in increased methylation of ATP5F1B gene CTD PMID:29501571 vanadium atom increases expression ISO RGD:1344847 6480464 Vanadium results in increased expression of ATP5F1B mRNA CTD PMID:19000753 vanadium(0) increases expression ISO RGD:1344847 6480464 Vanadium results in increased expression of ATP5F1B mRNA CTD PMID:19000753 vitamin E increases expression ISO RGD:1344847 6480464 Vitamin E results in increased expression of ATP5F1B mRNA CTD PMID:19244175